Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The BD Liverty™ TIPS Stent Graft Study

NCT: NCT05711316 · ACTIVE_NOT_RECRUITING

NCT IDNCT05711316
StatusACTIVE_NOT_RECRUITING
Start Date2023-08-08
Completion2027-01-11
SponsorC. R. Bard (INDUSTRY)
First posted
Last updated

Brief Summary

The objective of the study is to assess the safety and effectiveness of the BD Liverty™ TIPS Stent Graft for the treatment of the complications of portal hypertension from cirrhosis. This includes recurrent or refractory ascites, hepatic hydrothorax, and/or variceal bleeding (esophageal and/or gastric).

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑